Clinical trial • Phase I • Oncology
MEDI5752 for Metastatic soft tissue sarcoma
Phase I trial of MEDI5752 for Metastatic soft tissue sarcoma. 20 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Metastatic soft tissue sarcoma
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 17-07-2024
- First CTIS Authorization Date
- 09-08-2024
Trial design
Phase I trial across 5 sites in France.
- Target Sample Size
- 20
Recruitment
- Planned Sample Size
- 20
- Recruitment Window Months
- 54
Geography
- Total Number Of Sites
- 5
- Total Number Of Participants
- 20
France
- Earliest CTIS Part Ii Submission Date
- 10-07-2024
- Latest Decision Or Authorization Date
- 13-01-2025
- Processing Time Days
- 187
- Number Of Sites
- 5
- Number Of Participants
- 20
Sites
- Site Name
- Centre Oscar Lambret
- Department Name
- Medical oncology
- Principal Investigator Name
- Loïc LEBELLEC
- Principal Investigator Email
- l-lebellec@o-lambret.fr
- Contact Person Name
- Loïc LEBELLEC
- Contact Person Email
- l-lebellec@o-lambret.fr
- Site Name
- Institut Bergonie
- Department Name
- Medical oncology
- Principal Investigator Name
- Florent PEYRAUD
- Principal Investigator Email
- f.peyraud@bordeaux.unicancer.fr
- Contact Person Name
- Florent PEYRAUD
- Contact Person Email
- f.peyraud@bordeaux.unicancer.fr
- Site Name
- Oncopole Claudius Regaud
- Department Name
- Medical oncology
- Principal Investigator Name
- Thibaud VALENTIN
- Principal Investigator Email
- Valentin.Thibaud@iuct-oncopole.fr
- Contact Person Name
- Thibaud VALENTIN
- Contact Person Email
- Valentin.Thibaud@iuct-oncopole.fr
- Site Name
- Centre Leon Berard
- Department Name
- Medical oncology
- Principal Investigator Name
- Mehdi BRAHMI
- Principal Investigator Email
- mehdi.brahmi@lyon.unicancer.fr
- Contact Person Name
- Mehdi BRAHMI
- Contact Person Email
- mehdi.brahmi@lyon.unicancer.fr
- Site Name
- Institut Regional Du Cancer De Montpellier
- Department Name
- Medical oncology
- Principal Investigator Name
- Nelly FIRMIN
- Principal Investigator Email
- nelly.firmin@icm.unicancer.fr
- Contact Person Name
- Nelly FIRMIN
- Contact Person Email
- nelly.firmin@icm.unicancer.fr
Sponsor
Primary sponsor
- Full Name
- Oncopole Claudius Regaud
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- France
Investigational products
- Investigational Product Name
- MEDI5752
- Combination Treatment
- Yes
Related trials
Other published trials that may interest you.
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer
- AZD9833 for Estrogen receptor-positive HER2-negative advanced breast cancer
- Pembrolizumab for Classical Hodgkin lymphoma | Melanoma | Solid tumours (MSI-H/dMMR) | Solid tumours (TMB-H)